| Stem Cells - The proper implementation of stem cell-based disease models |
|
|
|
|
| |
|
| |
The latest stem cells news from News Medical |
|
|
|
 | | |
 Non-Viral Cell Engineering Technology for Clinical Development
MaxCyte's non-viral cell engineering technology provides the required efficiency, viability, and safety to attain the necessary therapeutic index, as well as the scalability and regulatory expertise to rapidly navigate clinical development — all while eliminating the cost, complexity, inconsistency, and potential toxicities of viral vectors.
| |
|
|
|
|
| | |  Respiratory viral infections pose significant morbidity and mortality to patients with chronic lung diseases like emphysema and COPD, causing exacerbations that drive destruction of normal lung tissue, and leading to one of the most common diagnoses for hospital admissions. | | | | |  When the first symptoms of Parkinson’s disease are experienced by a patient, the disease has been evolving for a long period, and the patient might already have lost half of a certain kind of nerve cells in the brain. | | | | |  New multi-institutional phase 3 clinical trial data published May 2 in Cell Reports Medicine found that a cancer stem cell test can accurately decide more effective treatments and lead to increased survival for patients with glioblastoma, a deadly brain tumor. | | | | |  The Stem Cell and Bone Marrow Transplant Program at Cedars-Sinai Cancer was recently recognized with two important hallmarks of quality: official accreditation for CAR T-cell therapy, and a third year in a row ranking among the top adult bone marrow transplant programs in the U.S. | |
|
|
|
|
|
|
